• Skip to main content
  • Skip to primary sidebar

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

Portfolio

/ January 13, 2021

Lacerta Group

Lacerta

Lacerta Group is a leading specialty materials company focused on developing and manufacturing innovative thermoformed packaging solutions, primarily made with polyethylene terephthalate (PET) and polypropylene (PP). The Company offers a comprehensive product portfolio and in-house design capabilities, with a customer-centric business model primarily focused on the food end-market. Lacerta specializes in sustainable packaging, as its products can be made with up to 100% recycled content, and almost all of its products are 100% recyclable.

SK Capital acquired a majority interest in Lacerta Group in December 2020.

For more information, please visit: www.lacerta.com.

Primary Sidebar

Latest News

  • Lacerta Group Announces Acquisition of Portage Plastics Assets

    January 9, 2023
  • SK Capital Announces Promotions

    January 3, 2023
  • SK Capital Partners and Edgewater Capital Partners Close Acquisition of Crystals Business from Saint-Gobain

    December 1, 2022

SK Capital Portfolio Companies

  • Luxium Solutions
  • VanDeMark Chemical, Inc
  • Valtris Specialty Chemicals
  • Florachem
  • Heubach
  • Seqens
  • Deltech LLC
  • Canlak
  • IPACKCHEM
  • Woodstock Sterile Solutions
  • Lacerta Group
  • Venator
  • Tilley Distribution
  • NuCera Solutions
  • Techmer PM
  • GEON
  • SI Group
  • Perimeter Solutions
  • Wavelength
  • Foremark
  • Tri-Tex
  • Niacet
  • Noramco
  • Extractas Bioscience
  • Purisys
  • Archroma
  • Addivant
  • TPC Group
  • Ascend
  • IBA Molecular
  • Calabrian Corporation
  • Halo Pharmaceutical
  • AEB Group

To request for a copy of our ESG report, please click here.

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login